Stay updated on TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study page content remains substantively unchanged between the screenshots; only cosmetic formatting differences are present and no edits to eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:19:31.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.
    Difference
    4%
    Check dated 2025-10-06T04:26:55.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:46:29.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:57:00.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.2%
    Check dated 2025-09-07T07:47:55.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and specific location details, as well as a comprehensive list of new therapeutic agents and proteins. Notably, the revision number has been updated to v3.0.0.
    Difference
    3%
    Check dated 2025-08-31T01:06:53.000Z thumbnail image

Stay in the know with updates to TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.